Clinical Trials Directory

Trials / Conditions / Stage II Non-Small Cell Lung Cancer

Stage II Non-Small Cell Lung Cancer

8 registered clinical trials studyying Stage II Non-Small Cell Lung Cancer.

StatusTrialSponsorPhase
Active Not RecruitingOsimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
NCT03433469
University of California, San FranciscoPhase 2
TerminatedNivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Ca
NCT03366766
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 2
CompletedTG4010 and Nivolumab in Patients With Lung Cancer
NCT02823990
Megan Daly, MDPhase 2
CompletedPembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Smal
NCT02621398
Rutgers, The State University of New JerseyPhase 1
TerminatedFeasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma
NCT02319889
Case Comprehensive Cancer CenterEARLY_Phase 1
TerminatedBevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Adv
NCT00369551
National Cancer Institute (NCI)Phase 1
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
CompletedVaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
NCT00019006
National Cancer Institute (NCI)Phase 1